<DOC>
	<DOCNO>NCT02506452</DOCNO>
	<brief_summary>The purpose study compare wound closure outcome subject receive diabetic foot ulcer treatment without use Biovance® .</brief_summary>
	<brief_title>Postmarket Study Evaluate Biovance® Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>The subject : 1. diagnose Diabetes Mellitus ( insulin noninsulin dependent ) peripheral neuropathy ( loss protective sensation ) affect foot 2. HbA1c less 10 % assess within last 12 week 3. fullthickness diabetic neuropathic foot ulcer free tunnels/sinus track , necrotic tissue , expose bone and/or tendon , osteomyelitis post debridement ( Wagner 1 2 ; Appendix I ) 4. one ( target ) diabetic neuropathic foot ulcer le 12 month duration area measure ≥ 1.5 ≤ 10 cm2 post debridement ( max length x max width ) screen surface part foot ( fore , mid hindfoot ) etiology relate loss protective sensation foot . 5. target ulcer close &lt; 30 % 2 week runin period ( 2 week management SOC follow signature inform consent prior potential randomization ) 6. sufficient arterial supply affect foot test within past 60 day The subject : 1. ulcer nondiabetic etiology study foot 2. target ulcer clinically infected underlie osteomyelitis time study treatment initiation 3. clinical evidence gangrene part affect foot 4. target ulcer expose bone tendon 5. malignancy neoplasm target ulcer site 6. active Charcot Foot Charcot Foot unable offload ( stable , nonactive Charcot deformity able offload acceptable ) 7. 3 ulcer study foot , include target ulcer , ulcer must least 3 cm remove target ulcer 8. significant comorbid disease may interfere wind heal 9. received chemotherapy , radiotherapy , immunosuppressant corticosteroid ( great 10 mg prednisoneequivalent per day ) within past 30 day . 10. diabetic foot ulcer treat experimental drug/biologic/device , livecell therapy ( experimental market ) , active moist wound heal therapy within 30 day randomization day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>